Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembroli…

Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech or the Company, 6990.HK) today announced that its TROP2-directed ...